Independent studies on European/UK growth stage biotech leadership remuneration and diversity
PIR International’s EU/UK Biotech Remuneration & Diversity Studies are data-driven resources that empower executives, investors and the boardroom with the insights they need to improve board governance, top-level business decisions and truly excel. These strictly independent, anonymised and confidential remuneration studies are designed to leverage participation from the entire European and UK biotech ecosystem that will give the very latest data to drive important insights for all decision-makers in the sector.
Our Board focused study report, releasing in January 2025 and our C-Suite focused study report released January 2024 respectively, dissect remuneration, participation, equity level, geographic and diversity representation, in correlation to key metrics such as investment level, founder status and other quantitative and qualitative measures. All aimed to give the latest and actionable insights for company governance in the European and UK biotech sector.
